Home NDC 70594-067 Voriconazole
Product NDC 70594-067
11-digit product format 705940067
Labeler code 70594
Product ID 70594-067_794911b6-dd66-445a-b73d-5037552e0b94
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Voriconazole
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Xellia Pharmaceuticals USA LLC
Application NDA208562
Marketing category NDA
Marketing start 2023-08-24
Substance VORICONAZOLE
Active strength 10 mg/mL
Pharmacologic classes Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N208562-001 VORICONAZOLE VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N208562-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Voriconazole
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength VORICONAZOLE 10 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination JFU09I87TR Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 351209 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70594-067-01 Voriconazole 20 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, LYOPHILIZED, 20 8 70594-067-01 Voriconazole 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70594-067 VORICONAZOLE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [XELLIA PHARMACEUTICALS USA LLC] 8 Current NDC, Legacy NDC, 2 package rows 20240402_9ec6eda2-2f15-423b-9ec6-819379a426e1.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 70594-067-01 70594006701 1 VIAL, SINGLE-DOSE in 1 CARTON (70594-067-01) / 20 mL in 1 VIAL, SINGLE-DOSE 2023-08-24 0000-00-00 No No Current